X0609 4/A 2026-01-27 2026-01-29 0000811641 IMMUCELL CORP /DE/ ICCC 0002095704 te Boekhorst Paul Francis Olivier false C/O IMMUCELL CORPORATION 56 EVERGREEN DRIVE PORTLAND ME 04103 1 1 President and CEO 0 Stock Options (right to buy) 6.265 2026-01-27 4 A 0 109500 0 A 2036-01-27 Common Stock 109500 109500 D This amendment amends the previously reported transaction effective on 1/27/2026 to disclose the correct number of shares included in the option award. Option grant made to Mr. te Boekhorst in connection with his employment as President and CEO. The option shall be treated as an incentive stock option to the maximum extent permitted by the Internal Revenue Code of 1986, as amended, with the balance treated as nonqualified stock option. One hundred percent of the stock option will vest when the Issuer's net operating income for four consecutive calendar quarters equals or exceeds 300% of the Issuer's audited net operating income for its 2025 fiscal year. /s/ Timothy C. Fiori Attorney-in-Fact 2026-03-23